Latest stories

  • in

    CCI approves acquisition of up to 76.10 percent of voting share capital of Suven Pharma by Berhyanda

    New Delhi: Anti-trust regulator Competition Commission of India (CCI) approves the acquisition of up to 76.10% of the voting share capital of Suven Pharmaceuticals Limited by Berhyanda Limited. The proposed combination relates to acquisition by Berhyanda Limited (Acquirer) for up to 76.10% of the voting share capital of Suven Pharmaceuticals Limited (Target), by way of a […] More

  • in

    PGI Chandigarh approves long pending demands for Paid Maternity Leave Benefits to PG Medical Students

    Chandigarh: Bringing good news to the female Postgraduate medical students pursuing MD/MS and DM/MCh courses, the Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh has approved them maternity leave benefits. Issuing an Office order in this regard, the institute mentioned, “Sanction is hereby accorded for the grant of Maternity Leave Benefits to female senior/junior residents […] More

  • in

    USFDA approves Zydus Lifesciences Tavaborole Topical Solution to treat fungal toenail infections

    USFDA approves Zydus Lifesciences Tavaborole Topical Solution to treat fungal toenail infections

    Ahmedabad: Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA) to manufacture and market Tavaborole Topical Solution, 5% (USRLD: Kerydin Topical Solution). Tavaborole topical solution is indicated to treat fungal toenail infections. These are the infections that may cause nail discoloration, splitting, or pain. The drug will be […] More

  • in

    NMC approves 2 new medical colleges with 100 MBBS seats each in Telangana

    NMC approves 2 new medical colleges with 100 MBBS seats each in Telangana

    Hyderabad: Giving a reason to medical aspirants to celebrate, the National Medical Commission (NMC) has given its nod to two more new medical colleges in Kamareddy and Komaram Bheem Asifabad districts of Telangana with 100 MBBS seats in each college for the academic year 2023-24. The announcement in this regard was made by Health Minister […] More

  • in

    CDSCO panel approves Reliance Life Science’s Phase III CT Protocol for Tocilizumab

    CDSCO panel approves Reliance Life Science's Phase III CT Protocol for Tocilizumab

    New Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has approved Reliance Life Science’s Phase III clinical trial protocol of immunosuppressive Tocilizumab with some changes in exclusion criteria. This came after the firm presented the proposal to conduct a Phase III clinical trial titled “A prospective, multicenter, randomized, […] More

  • in

    Health Canada approves Chiesi Ferriprox MR Deferiprone ER tablets for patients with transfusional iron overload

    Delhi: Chiesi Global Rare Diseases, a business unit of the Chiesi Group established to deliver innovative therapies and solutions for people affected by rare diseases, announced that Health Canada has approved Ferriprox MR deferiprone extended-release tablets 1 000 mg for the treatment of patients with transfusional iron overload due to thalassemia syndromes when current chelation […] More

  • in

    FDA approves RemeOs trauma screw as first bioresorbable metal implant for marketing

    The Food and Drug Administration has granted market authorization to Bioretec for its RemeOs trauma screw which is designed to aid fixation for patients with ankle fractures. The benefits of the RemeOs trauma screw have been validated in clinical trials and have already previously been recognized by the FDA granting the Breakthrough Device Designation. Bioresorbable […] More